

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Hemodialysis Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled “Hemodialysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022 -2027
”, the global hemodialysis market size reached US$ 83.3 Billion in 2021.
Hemodialysis is a procedure for treating kidney failure patients in which wastes, salts, and fluids are removed from their blood using a dialyzer, or an artificial kidney. It is performed when the kidney function falls below 10%-15% for the purpose of restoring electrolyte balance. It prevents salts and other toxins from accumulating in the body, removes waste products, such as creatinine and urea from the blood, and improves kidney function. Besides dialyzers, bloodlines, catheters, and dialysate are some of the medical equipment used in the process. Furthermore, it helps regulate blood pressure levels and maintain proper concentrations of minerals, such as sodium, potassium, and calcium in the body. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report:
https://www.imarcgroup.com/hemodialysis-market/requestsample
The global market is primarily driven by the rising incidences of chronic kidney diseases (CKD), acute kidney injury (AKI), and end-stage renal disease (ESRD). It can be attributed to a considerable increase in the geriatric population that is more prone to developing renal failures. In line with this, the shortage of organ donors due to the risks associated with transplants is resulting in a higher product uptake. Moreover, the growing consumer awareness regarding early diagnosis and treatment of kidney disorders is providing an impetus to the market.
Apart from this, continual product innovations, such as the advent of compact-sized home-treatment machines, are creating a positive outlook for the market. Some of the other factors contributing to the market include favorable government policies for improving healthcare infrastructure, rapid digitization in the medical sector and treatment automation, and extensive research and development (R&D) activities.
On account of the aforementioned factors, the market is anticipated to reach a value of US$ 107.8 Billion by 2027, exhibiting a CAGR of 4.5% during 2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/hemodialysis-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Segment:
• Hemodialysis Product
• Machines
• Dialyzers
• Others
• Hemodialysis Service
• In-center Services
• Home Services
Breakup by Modality:
• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis
Breakup by Modality:
• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis
Breakup by End-User:
• Hospitals
• Independent Dialysis Centres
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Baxter International
• Asahi Kasei Corporation
• B. Barun Melsungen
• DaVita
• Cantel Medical Corporation
• Fresenius Medical Care
• Nipro Corporation
• Rockwell Medical
• Medivators
• Toray Medical Company Ltd.
• Nikkiso Co. Ltd.
• Surni Group
• Gambro
• Satellite Healthcare Inc.
• Renacon Pharma Ltd.
1. How has the global hemodialysis market performed so far and how will it perform in the coming years?
2. What are the key regional markets in the global hemodialysis industry?
3. What has been the impact of COVID-19 on the global hemodialysis industry?
4. What is the breakup of the market based on the segment?
5. What is the breakup of the market based on the product?
6. What is the breakup of the market based on the service?
7. What is the breakup of the market based on the modality?
8. What is the breakup of the market based on the end-user?
9. What are the various stages in the value chain of the global hemodialysis industry?
10. What are the key driving factors and challenges in the global hemodialysis industry?
11. What is the structure of the global hemodialysis industry and who are the key players?
12. What is the degree of competition in the global hemodialysis industry?
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/hemodialysis-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.